Home › Cancer (all types) › NCT07718204

The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

MedMemos: An Intervention to Promote Medication Adherence in Pediatric Allogenic Hematopoietic Stem Cell Transplantation

Who can join

Ages 0 to 12 · All sexes

Inclusion Criteria:

* Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT)
* Child is 0-12 years of age
* At the time of recruitment child is still in the hospital for PAHCT
* Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate
* Child is prescribed an oral medication regimen at discharge

Exclusion Criteria:

* Caregiver does not speak English, Spanish, or Arabic
* Caregiver is not available to provide written permission for the child's participation
* EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires
* The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver
* Caregiver is unwilling to store medication in an electronic monitor

About the study

The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are:

* Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better?

Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.

What is being tested

• MedMemos (behavioral)

Sponsor: Nationwide Children's Hospital · Participants: 25 · Started: May 1, 2026

Contact the study team

• Ahna LH Pai, PhD · Phone: (614) 938-1601
• Sarah N Drake, MS · Phone: (614) 259-7462

Official record on ClinicalTrials.gov — NCT07718204

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.